Home /  Lawyers /  Miaoting (Mimi) Wu

    Miaoting (Mimi) Wu

    Associate

    Miaoting (Mimi) Wu Headshot Photo Portrait backdrop

    New York

    +1-212-558-4000

    |

    wum@sullcrom.com

    Email vCard PDF

    Mimi Wu is an associate in the Firm’s Mergers & Acquisitions Group. She advises clients on M&A and restructuring transactions, governance matters and financial advisory matters. She has assisted with representing clients in the consumer & retail, energy, technology and healthcare & life sciences industries.

    Experience

    • Abiomed (U.S.) in its $18 billion acquisition by Johnson & Johnson (U.S.), the largest all-cash medtech deal in history
    • Amgen (U.S.) in its $28.3 billion pending acquisition of Horizon Therapeutics (Ireland)
    • Biohaven Pharmaceuticals (U.S.) in its $11.6 billion acquisition by Pfizer (U.S.)
    • LSC Communications (U.S.) in its acquisition by Atlas Holdings (U.S.) as part of the LSC Chapter 11 bankruptcy, 363 asset sale process
    • Symbotic (U.S.) in its $5.5 billion merger with SVF Investment Corp. 3 (U.S.), a SPAC sponsored by an affiliate of Softbank Investment Advisers (U.K.)

    News

    Read More

    Credentials

    Education

    • Columbia Law School, J.D., 2015
    • Columbia University, M.B.A., 2015
    • Yale University, B.A., 2012

    Bar Admissions

    • New York

    Related Practices